Newsletter | January 16, 2024

01.16.24 -- A Supply Chain Case Study With A Lesson For All Therapies

FEATURED EDITORIAL

A Supply Chain Lesson For All Therapies

Transparently incorporating a secondary supplier (CDMO) into its clinical supply planning helped a pharma company overcome some thorny challenges.

INDUSTRY INSIGHTS

Providing Drug Supply Support In Complex Environments Through IRT

Learn how applying predictive data analytics can enable the creation of an ideal supply strategy capable of reducing the need for extra shipments, manual oversight, and supply waste.

A Randomization And Trial Supply Management Approach To Track And Trace

How can a randomization and trial supply management approach to track and trace help improve its efficiency and efficacy? Find the answer in this white paper.

Reaching First-In-Human Trials Faster: Connect With The Right Partner

Assessing outsourcing partners’ credentials in these key departments will make all the difference as sponsors aim to mitigate risk and streamline processes on the path to commercialization.

Optimizing Storage & Distribution In An Era Of Clinical Trial Transformation

Explore the rapidly evolving complexities of clinical storage and distribution and how customized and patient-centric solutions have never been more paramount to support the healthcare of tomorrow.

Clinical Manufacturing: What It Is And How It Works

Clinical manufacturing is a specialized form of pharmaceutical manufacturing focused on producing drugs for clinical research. How does it work and how is it different from commercial manufacturing?

Key Considerations When Selecting Packaging Components

Recognizing the importance of packaging development and prioritizing its role in drug development early on can help proactively identify potential delays and overcome risks.

The Difference A Full-Service RTSM Can Make For Study Managers

See how a full-service randomization and trial supply management solution, the next evolution of technologies like interactive response systems, can maximize efficiencies in clinical trials.

Investigational Medicinal Products: Labeling Changes And Their Implications

Learn about Annex VI, which covers changes in the labeling requirements for investigational medicinal products (IMPs) and harmonizes them throughout EU countries.

SOLUTIONS

An Early-Phase, Raw-Material, Clinical Manufacturing Case Study

Simplify Logistics With Total Transportation Management

Rave RTSM: A Unique Platform-Based Approach To IRT

Dual Sourcing: Mitigating Risk In Your Supply Chain